ReviewCureus2025
From Repair to Prevention: The Emerging Role of Preventive Orthopedics.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Musculoskeletal (MSK) conditions are leading causes of global disability and major drivers of healthcare utilization, surgeries, and productivity loss, with low back pain, osteoarthritis, and fragility fractures contributing most to the burden and expected to rise due to aging, obesity, and sedentary lifestyles. Work-related MSK disorders remain highly prevalent and are costly. This narrative review aimed to synthesize current preventive orthopedic strategies across the life course. Evidence was drawn from systematic reviews, meta-analyses, clinical guidelines, economic evaluations, and targeted searches, following best-practice standards for transparent narrative reviews. Preventive orthopedics integrates risk stratification; neuromuscular and ergonomic interventions; lifestyle-first osteoarthritis management; fall and fracture prevention, including osteoporosis screening and fracture liaison services; workplace MSK programs; perioperative prehabilitation; digital health technologies; and emerging pharmacologic strategies such as glucagon-like peptide-1 (GLP-1)-based weight management. These interventions demonstrate reductions in injury rates, improvements in pain and function, and meaningful health system efficiencies. Persistent challenges include adherence, implementation fidelity, reporting quality, and equitable access. Future priorities include pragmatic and equity-focused trials and clearer operationalization of prevention across musculoskeletal care pathways.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.